CLINICAL OUTCOMES OF LOW AND INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER PATIENTS TREATED WITH 30MCI FOR ABLATION OR WITHOUT RADIOACTIVE IODINE THERAPY

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

ABSTRACT Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine remnant ablation (RRA) and to compare them to patients receiving low dose of iodine (30 mCi).Subjects and methods A total of 189 differentiated thyroid can

read more



Analysis of Nanotoxicity with Integrated Omics and Mechanobiology

Nanoparticles (NPs) in biomedical applications have benefits owing to their small size.However, their intricate and sensitive nature makes an evaluation of the adverse effects of NPs on health necessary and challenging.Since there are limitations to conventional toxicological methods and omics analyses provide a more comprehensive molecular profili

read more

pH-responsive hierarchical H2S-releasing nano-disinfectant with deep-penetrating and anti-inflammatory properties for synergistically enhanced eradication of bacterial biofilms and wound infection

Abstract Background Methicillin-resistant Staphylococcus aureus (MRSA) biofilm-associated bacterial infection is the primary cause of nosocomial infection and has long been an ongoing threat to public health.MRSA biofilms are often resistant to multiple antimicrobial strategies, mainly due to the existence of a compact protective barrier; thus, pro

read more